Actinium Pharmaceuticals, Inc. (ATNM) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Actinium Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | -1.25x |
| P/B Ratio | 5.42x |
| P/S Ratio | 471.40x |
| Profitability | |
| Gross Margin | 100.0% |
| Operating Margin | -40274.4% |
| Net Margin | -37652.2% |
| EBITDA Margin | -39362.2% |
| Liquidity | |
| Current Ratio | 6.20x |
| Quick Ratio | 6.20x |
| Leverage | |
| Debt/Equity | 0.22x |
YoY = year-over-year change. Source: FMP..